ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
March 17, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital...
ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
March 14, 2022 09:00 ET
|
ResMed Inc.
Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep have benefitted from remote working, and many are concerned waking...
ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
March 10, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare...
ResMed Announces Participation in the Citi Healthcare Conference
February 16, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare...
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
February 01, 2022 09:00 ET
|
ResMed Inc.
Tyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBMCurrent CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-time SAN...
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
January 27, 2022 16:05 ET
|
ResMed Inc.
Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at...
ResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
January 06, 2022 16:05 ET
|
ResMed Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on...
ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
January 03, 2022 09:00 ET
|
ResMed Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on...
ResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
December 30, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs...
ResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
November 19, 2021 09:00 ET
|
ResMed Inc.
Tan is vice president and managing director of Microsoft’s Health and Life Science R&D Hernandez is Google’s head of clinical research, health economics, and outcomes researchBoth leaders’ digital...